Strategic approaches to osteoporosis in transplantation

Pediatric Transplantation

Volumn 8, Issue SUPPL. 5, 2004, Pages 51-55

  Mattano Jr , Leonard A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adolescent; Child; Osteoporosis; Review; Stem cell transplantation

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN A; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYELOABLATIVE AGENT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; TACROLIMUS;

ADOLESCENT; AGE; BONE DEMINERALIZATION; BONE DENSITY; BONE MINERAL; BONE TOXICITY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIAGNOSTIC IMAGING; DRUG TOXICITY; DUAL ENERGY X RAY ABSORPTIOMETRY; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM EXPOSURE; LONGITUDINAL STUDY; OSTEOPENIA; OSTEOPOROSIS; REFLUX ESOPHAGITIS; RETINOL DEFICIENCY; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW;

ADOLESCENT; BONE DENSITY; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 2942726467     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-2265.2004.00184.x     Document Type: Conference Paper

References (54)

1. MASSENKEIL G, FIENE C, ROSEN O, et al. Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: Standard prophylactic measures fail to prevent osteoporosis. Leukemia 2001: 15: 1701-1705.
2. PFEILSCHIFTER J, DIEL IJ. Osteoporosis due to cancer treatment: Pathogenesis and management. J Clin Oncol 2000: 18: 1570-1593.
3. WEILBAECHER KN. Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000: 6: 165-174.
4. SEEMAN E. Pathogenesis of bone fragility in women and men. Lancet 2002: 359: 1841-1850.
5. LEONARD MB, ZEMEL BS. Current concepts in pediatric bone disease. Pediatr Clin North Am 2002: 49: 143-173.
6. WEINSTEIN RS, MANOLAGAS SC. Apoptosis and osteoporosis. Am J Med 2000: 108: 153-164.
7. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement 2000, PMID: 11525451 March 27-29: 17: 1-36.
8. AISENBERG J, HSIEH K, KALAITZOGLOU G. et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol 1998: 20: 241-245.
9. ARIKOSKI P, KOMULAINEN J, VOUTILAINEN R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998: 20: 234-240.
10. HADDY TB, MOSHER RB, REAMAN GH. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist 2001: 6: 278-285.
11. KASTE SC, JONES-WALLACE D, ROSE SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 2001: 15: 728-734.
12. STRAUSS AJ, SU JT, KIMBALL DALTON VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001: 19: 3066-3072.
13. VAN DER SLUIS IM, VAN DEN HEUVEL-EIBRINK MM, HÄHLEN K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002: 141: 204-210.
14. World Health Organization. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Geneva, Switzerland: World Health Organization, 1994. Technical Report Series 893.
15. TOTHILL P, HANNAN WJ. Bone mineral and soft tissue measurements by dual-energy X-ray absorptiometry during growth. Bone 2002: 31: 492-496.
16. NEU CM, MANZ F, RAUCH F, et al. Bone densities and bone size at the distal radius in healthy children and adolescents: A study using peripheral quantitative computed tomography. Bone 2001: 28: 227-232.
17. RADSPIELER H, DAMBACHER MA, KISSLING R, et al. Is the amount of trabecular bone-loss dependent on bone mineral density? A study performed by three centres of osteoporosis using high resolution peripheral quantitative computed tomography. Eur J Med Res 2000: 5: 32-39.
18. RAUCH F, SCHOENAU E. Changes in bone density during childhood and adolescence: An approach based on bone's biological organization. J Bone Miner Res 2001: 16: 597-604.
19. KANIS JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002: 359: 1929-1936.
20. GOULDING A, JONES IE, TAYLOR RW, et al. More broken bones: A 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000: 15: 2011-2018.
21. KASHYAP A, KANDEEL F, YAMAUCHI D, et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study. Biol Blood Marrow Transplant 2000: 6: 344-351.
22. EBELING PR, THOMAS DM, ERBAS B, et al. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999: 14: 342-350.
23. KANG MI, LEE WY, OH KW, et al. The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 2000: 26: 275-279.
24. VÄLIMÄKI MJ, KINNUNEN K, VOLIN L, et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: Effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999: 23: 355-361.
25. LEE WY, KANG MI, BAEK KH, et al. The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study. J Korean Med Sci 2002: 17: 749-754.
26. KANANAN K, VOLIN L, TÄHTELÄ R, et al. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 2002: 29: 33-39.
27. TAUCHMANOVÁ L, SERIO B, DEL PUENTE A, et al. Long-lasting bone damage detected by dual-energy X-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2002: 87: 5058-5065.
28. BHATIA S, RAMSEY NKC, WEISDORF D, et al. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone marrow Transplant 1988: 22: 87-90.
29. NYSOM K, HOLM K, MICHAELSEN KF, et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2000: 25: 191-196.
30. BANFI A, PODESTA M, FAZZUOLI L, et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors. A mechanism for post-bone marrow transplantation osteopenia. Cancer 2001: 92: 2419-2428.
31. SCHIMMER AD, MAH K, BORDELEAU L, et al. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant 2001: 28: 387-391.
32. GALOTTO M, BERISSO G, DELFINO L, et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999: 27: 1460-1466.
33. DAVIES JH, EVANS BAJ, JENNEY MEM, et al. In vitro effects of combination chemotherapy on osteoblasts: Implications for osteopenia in childhood malignancy. Bone 2002: 31: 319-326.
34. HOFBAUER LC, NEUBAUER A, HEUFELDER AE. Receptor activator of nuclear factor-κB ligand and osteoprotegerin. Potential implications for the pathogenesis and treatment of malignant bone diseases. Cancer 2001: 92: 460-470.
35. O'GORMAN DM, COTTER TG. Molecular signals in anti-apoptotic survival pathways. Leukemia 2001: 15: 21-34.
36. SASAKI N, KUSANO E, ANDO Y, et al. Changes in ostroprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. Bone 2002: 30: 853-858.
37. MOCHIZUKI S, FUJISE N, HIGASHIO K, et al. Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats. J Bone Miner Metab 2002: 20: 14-20.
38. HALASY-NAGY JM, RODAN GA, RESZKA AA. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 2001: 29: 553-559.
39. SAAG KG, EMKEY R, SCHNITZER TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. The Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 1998: 339: 292-299.
40. VIERECK V, EMONS G, LAUCK V, et al. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 2002: 291: 680-686.
41. ABDELHADI M, ERICZON B-G, HULTENBY K, et al. Structural skeletal impairment induced by immunosuppressive therapy in rats: Cyclosporine A vs tacrolimus. Transplant Int 2002: 15: 180-187.
42. STEELMAN J, ZEITLER P. Osteoporosis in pediatrics. Pediatr Rev 2001: 22: 56-65.
43. BONJOUR J-P, CHEVALLEY T, AMMANN P, et al. Gain in bone mineral mass in prepubertal girls 3-5 years after discontinuation of calcium supplementation: A follow-up study. Lancet 2001: 358: 1208-1212.
44. JANZ KF, BURNS TL, TORNER JC, et al. Physical activity and bone measures in young children: The Iowa Bone Development Study. Pediatrics 2001: 107: 1387-1393.
45. MACKELVIE KJ, MCKAY HA, KHAN KM, et al. A school-based exercise intervention augments bone mineral accrual in early pubertal girls. J Pediatr 2001: 139: 501-508.
46. MANOLAGAS SC, WEINSTEIN RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999: 14: 1061-1066.
47. ASTROM E, SODERHALL S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 2002: 86: 356-364.
48. BIANCHI ML, CIMAZ R, BARDARE M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: A prospective multicenter study. Arthritis Rheum 2000: 43: 1960-1966.
49. BRUMSEN C, HAMDY NAT, PAPAPOULOS SE. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine 1997: 76: 266-283.
50. O'SULLIVAN M, ZACHARIN M. Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome. J Pediatr Orthop 2002: 22: 255-260.
51. SHOEMAKER LR. Expanding role of bisphosphonate therapy in children. J Pediatr 1999: 134: 264-267.
52. WIERNIKOWSKI JT, BARR RD, ATKINSON SA, et al. Alendronate for steroid induced osteopenia in children with acute lymphoblastic leukemia (ALL): results of a pilot study. Med Pediatr Oncol 2002: 39: 293.
53. BARR RD, GUO CY, WIERNIKOWSKI J, et al. Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate. Med Pediatr Oncol 2002: 39: 44-46.
54. MUNDY GR. Statins and their potential for osteoporosis. Bone 2001: 29: 495-497.